{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:17:04Z","timestamp":1793906224278,"version":"4.8.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12035-025-04715-w","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:07:20Z","timestamp":1738084040000},"page":"7296-7312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer\u2019s Disease and Regulation by Natural Plant Products"],"prefix":"10.1007","volume":"62","author":[{"given":"Runru","family":"Zu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiran","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quekun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"4715_CR1","unstructured":"(2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health 7:e105\u2013e125"},{"key":"4715_CR2","doi-asserted-by":"crossref","unstructured":"(2023) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 19(4):1598\u20131695","DOI":"10.1002\/alz.13016"},{"key":"4715_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1474-4422(22)00529-4","volume":"22","author":"S Mead","year":"2023","unstructured":"Mead S, Fox NC (2023) Lecanemab slows Alzheimer\u2019s disease: hope and challenges. Lancet Neurol 22:106\u2013108","journal-title":"Lancet Neurol"},{"key":"4715_CR4","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(22)02480-1","volume":"400","author":"L The","year":"2022","unstructured":"The L (2022) Lecanemab for Alzheimer\u2019s disease: tempering hype and hope. Lancet 400:1899","journal-title":"Lancet"},{"key":"4715_CR5","doi-asserted-by":"publisher","first-page":"106314","DOI":"10.1016\/j.phrs.2022.106314","volume":"182","author":"L You","year":"2022","unstructured":"You L, Liang K, An R, Wang X (2022) The path towards FDA approval: a challenging journey for Traditional Chinese Medicine. Pharmacol Res 182:106314","journal-title":"Pharmacol Res"},{"key":"4715_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement 12:719\u2013732","journal-title":"Alzheimers Dement"},{"key":"4715_CR7","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"RY Pan","year":"2022","unstructured":"Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J et al (2022) Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab 34:634\u2013648","journal-title":"Cell Metab"},{"key":"4715_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd.2018.149","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 17:688","journal-title":"Nat Rev Drug Discov"},{"key":"4715_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575:669\u2013673","journal-title":"Nature"},{"key":"4715_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11011-021-00886-2","volume":"37","author":"L Shao","year":"2022","unstructured":"Shao L, Dong C, Geng D, He Q, Shi Y (2022) Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer\u2019s disease. Metab Brain Dis 37:329\u2013341","journal-title":"Metab Brain Dis"},{"key":"4715_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417\u2013426","journal-title":"Mol Cell"},{"key":"4715_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373\u2013384","journal-title":"Nat Immunol"},{"issue":"9","key":"4715_CR13","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1093\/jimmunol\/191.9.4475","volume":"191","author":"CA Janeway Jr","year":"2013","unstructured":"Janeway CA Jr (2013) Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol 1989. J Immunol 191(9):4475\u20134487","journal-title":"J Immunol"},{"key":"4715_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li D, Wu M (2021) Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 6:291","journal-title":"Signal Transduct Target Ther"},{"key":"4715_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D et al (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787\u2013791","journal-title":"J Immunol"},{"key":"4715_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H (2023) Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol 41:301\u2013316","journal-title":"Annu Rev Immunol"},{"issue":"13","key":"4715_CR17","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20(13):3328","journal-title":"Int J Mol Sci"},{"key":"4715_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang H, Kouadir M, Song H, Shi F (2019) Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis 10:128","journal-title":"Cell Death Dis"},{"key":"4715_CR19","doi-asserted-by":"publisher","first-page":"114070","DOI":"10.1016\/j.celrep.2024.114070","volume":"43","author":"T Yu","year":"2024","unstructured":"Yu T, Hou D, Zhao J, Lu X, Greentree WK, Zhao Q et al (2024) NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation. Cell Rep 43:114070","journal-title":"Cell Rep"},{"key":"4715_CR20","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1016\/j.molcel.2023.11.015","volume":"83","author":"S Zheng","year":"2023","unstructured":"Zheng S, Que X, Wang S, Zhou Q, Xing X, Chen L et al (2023) ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation. Mol Cell 83:4570\u20134857","journal-title":"Mol Cell"},{"key":"4715_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4049\/jimmunol.2300241","volume":"213","author":"D Hu","year":"2024","unstructured":"Hu D, Li Y, Wang X, Zou H, Li Z, Chen W et al (2024) Palmitoylation of NLRP3 modulates inflammasome activation and inflammatory bowel disease development. J Immunol 213:481\u2013493","journal-title":"J Immunol"},{"key":"4715_CR22","doi-asserted-by":"publisher","first-page":"114516","DOI":"10.1016\/j.celrep.2024.114516","volume":"43","author":"S Leishman","year":"2024","unstructured":"Leishman S, Aljadeed NM, Qian L, Cockcroft S, Behmoaras J, Anand PK (2024) Fatty acid synthesis promotes inflammasome activation through NLRP3 palmitoylation. Cell Rep 43:114516","journal-title":"Cell Rep"},{"key":"4715_CR23","doi-asserted-by":"publisher","first-page":"e113481","DOI":"10.15252\/embj.2023113481","volume":"42","author":"YJ Park","year":"2023","unstructured":"Park YJ, Dodantenna N, Kim Y, Kim TH, Lee HS, Yoo YS et al (2023) MARCH5-dependent NLRP3 ubiquitination is required for mitochondrial NLRP3-NEK7 complex formation and NLRP3 inflammasome activation. Embo j 42:e113481","journal-title":"Embo j"},{"key":"4715_CR24","doi-asserted-by":"publisher","first-page":"113752","DOI":"10.1016\/j.celrep.2024.113752","volume":"43","author":"J Ha","year":"2024","unstructured":"Ha J, Kim M, Park JS, Lee Y, Lee JY, Shin JC et al (2024) SERTAD1 initiates NLRP3-mediated inflammasome activation through restricting NLRP3 polyubiquitination. Cell Rep 43:113752","journal-title":"Cell Rep"},{"key":"4715_CR25","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1096\/fj.201901653R","volume":"34","author":"L Shao","year":"2020","unstructured":"Shao L, Liu Y, Wang W, Li A, Wan P, Liu W et al (2020) SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation. Faseb j 34:1497\u20131515","journal-title":"Faseb j"},{"key":"4715_CR26","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1038\/s41467-021-25033-4","volume":"12","author":"Y Qin","year":"2021","unstructured":"Qin Y, Li Q, Liang W, Yan R, Tong L, Jia M et al (2021) TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation. Nat Commun 12:4794","journal-title":"Nat Commun"},{"key":"4715_CR27","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1038\/s41467-018-05321-2","volume":"9","author":"R Barry","year":"2018","unstructured":"Barry R, John SW, Liccardi G, Tenev T, Jaco I, Chen CH et al (2018) SUMO-mediated regulation of NLRP3 modulates inflammasome activity. Nat Commun 9:3001","journal-title":"Nat Commun"},{"key":"4715_CR28","doi-asserted-by":"publisher","first-page":"8396","DOI":"10.1038\/s41467-023-44203-0","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Luo L, Xu X, Wu J, Wang F, Lu Y et al (2023) Acetylation is required for full activation of the NLRP3 inflammasome. Nat Commun 14:8396","journal-title":"Nat Commun"},{"key":"4715_CR29","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1038\/s41467-021-26142-w","volume":"12","author":"T Niu","year":"2021","unstructured":"Niu T, De Rosny C, Chautard S, Rey A, Patoli D, Groslambert M et al (2021) NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly. Nat Commun 12:5862","journal-title":"Nat Commun"},{"key":"4715_CR30","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/S0140-6736(19)30851-7","volume":"393","author":"R Barnett","year":"2019","unstructured":"Barnett R (2019) Alzheimer\u2019s disease. Lancet 393:1589","journal-title":"Lancet"},{"key":"4715_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25:59\u201370","journal-title":"Eur J Neurol"},{"key":"4715_CR32","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3233\/JAD-230567","volume":"96","author":"S Tao","year":"2023","unstructured":"Tao S, Fan W, Liu J, Wang T, Zheng H, Qi G et al (2023) NLRP3 inflammasome: an emerging therapeutic target for Alzheimer\u2019s disease. J Alzheimers Dis 96:1383\u20131398","journal-title":"J Alzheimers Dis"},{"key":"4715_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2174\/1389203722666210916141436","volume":"22","author":"EC de Brito Toscano","year":"2021","unstructured":"de Brito Toscano EC, Rocha NP, Lopes BNA, Suemoto CK, Teixeira AL (2021) Neuroinflammation in Alzheimer\u2019s disease: focus on NLRP1 and NLRP3 inflammasomes. Curr Protein Pept Sci 22:584\u2013598","journal-title":"Curr Protein Pept Sci"},{"key":"4715_CR34","doi-asserted-by":"publisher","first-page":"1214289","DOI":"10.3389\/fimmu.2023.1214289","volume":"14","author":"TSB Honda","year":"2023","unstructured":"Honda TSB, Ku J, Anders HJ (2023) Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis. Front Immunol 14:1214289","journal-title":"Front Immunol"},{"key":"4715_CR35","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB et al (2013) CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 14:812\u2013820","journal-title":"Nat Immunol"},{"key":"4715_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cells10071652","volume":"10","author":"C Panda","year":"2021","unstructured":"Panda C, Voelz C, Habib P, Mevissen C, Pufe T, Beyer C et al (2021) Aggregated Tau-PHF6 (VQIVYK) potentiates NLRP3 inflammasome expression and autophagy in human microglial cells. Cells. 10:10","journal-title":"Cells."},{"key":"4715_CR37","doi-asserted-by":"publisher","first-page":"109720","DOI":"10.1016\/j.celrep.2021.109720","volume":"36","author":"S Jiang","year":"2021","unstructured":"Jiang S, Maphis NM, Binder J, Chisholm D, Weston L, Duran W et al (2021) Proteopathic tau primes and activates interleukin-1\u03b2 via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway. Cell Rep 36:109720","journal-title":"Cell Rep"},{"key":"4715_CR38","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1038\/s41380-023-02239-0","volume":"28","author":"J Yao","year":"2023","unstructured":"Yao J, Wang Z, Song W, Zhang Y (2023) Targeting NLRP3 inflammasome for neurodegenerative disorders. Mol Psychiatry 28:4512\u20134527","journal-title":"Mol Psychiatry"},{"key":"4715_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W (2023) Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther 8:248","journal-title":"Signal Transduct Target Ther"},{"key":"4715_CR40","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/ejn.12235","volume":"37","author":"Y Deng","year":"2013","unstructured":"Deng Y, Wang Z, Wang R, Zhang X, Zhang S, Wu Y et al (2013) Amyloid-\u03b2 protein (A\u03b2) Glu11 is the major \u03b2-secretase site of \u03b2-site amyloid-\u03b2 precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to A\u03b2 Asp1 contributes to Alzheimer pathogenesis. Eur J Neurosci 37:1962\u20131969","journal-title":"Eur J Neurosci"},{"key":"4715_CR41","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1523\/JNEUROSCI.0340-17.2017","volume":"37","author":"S Zhang","year":"2017","unstructured":"Zhang S, Wang Z, Cai F, Zhang M, Wu Y, Zhang J et al (2017) BACE1 cleavage site selection critical for amyloidogenesis and Alzheimer\u2019s pathogenesis. J Neurosci 37:6915\u20136925","journal-title":"J Neurosci"},{"key":"4715_CR42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao BZ, Xu ZQ, Han BZ, Su DF, Liu C (2015) NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol 6:262","journal-title":"Front Pharmacol"},{"key":"4715_CR43","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 17:588\u2013606","journal-title":"Nat Rev Drug Discov"},{"key":"4715_CR44","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.4049\/jimmunol.164.12.6287","volume":"164","author":"E Junn","year":"2000","unstructured":"Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD et al (2000) Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 164:6287\u20136295","journal-title":"J Immunol"},{"key":"4715_CR45","doi-asserted-by":"publisher","first-page":"102735","DOI":"10.1016\/j.redox.2023.102735","volume":"63","author":"J Kim","year":"2023","unstructured":"Kim J, Lim J, Yoo ID, Park S, Moon JS (2023) TXNIP contributes to induction of pro-inflammatory phenotype and caspase-3 activation in astrocytes during Alzheimer\u2019s diseases. Redox Biol 63:102735","journal-title":"Redox Biol"},{"key":"4715_CR46","doi-asserted-by":"publisher","first-page":"101534","DOI":"10.1016\/j.redox.2020.101534","volume":"32","author":"Y Jia","year":"2020","unstructured":"Jia Y, Cui R, Wang C, Feng Y, Li Z, Tong Y et al (2020) Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway. Redox Biol 32:101534","journal-title":"Redox Biol"},{"key":"4715_CR47","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.272.5262.735","volume":"272","author":"A Surprenant","year":"1996","unstructured":"Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735\u2013738","journal-title":"Science"},{"key":"4715_CR48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1085\/jgp.200810059","volume":"132","author":"Z Yan","year":"2008","unstructured":"Yan Z, Li S, Liang Z, Tomi\u0107 M, Stojilkovic SS (2008) The P2X7 receptor channel pore dilates under physiological ion conditions. J Gen Physiol 132:563\u2013573","journal-title":"J Gen Physiol"},{"key":"4715_CR49","doi-asserted-by":"crossref","unstructured":"Ronning KE, D\u00e9chelle-Marquet PA, Che Y, Guillonneau X, Sennlaub F, Delarasse C (2023) The P2X7 receptor, a Multifaceted receptor in Alzheimer\u2019s disease. Int J Mol Sci 24(14):11747","DOI":"10.3390\/ijms241411747"},{"key":"4715_CR50","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1242\/jcs.034082","volume":"121","author":"M D\u00edaz-Hernandez","year":"2008","unstructured":"D\u00edaz-Hernandez M, del Puerto A, D\u00edaz-Hernandez JI, Diez-Zaera M, Lucas JJ, Garrido JJ et al (2008) Inhibition of the ATP-gated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons. J Cell Sci 121:3717\u20133728","journal-title":"J Cell Sci"},{"key":"4715_CR51","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.neurobiolaging.2011.09.040","volume":"33","author":"JI Diaz-Hernandez","year":"2012","unstructured":"Diaz-Hernandez JI, Gomez-Villafuertes R, Le\u00f3n-Otegui M, Hontecillas-Prieto L, Del Puerto A, Trejo JL et al (2012) In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer\u2019s disease through GSK3\u03b2 and secretases. Neurobiol Aging 33:1816\u20131828","journal-title":"Neurobiol Aging"},{"key":"4715_CR52","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Mu\u00f1oz-Planillo","year":"2013","unstructured":"Mu\u00f1oz-Planillo R, Kuffa P, Mart\u00ednez-Col\u00f3n G, Smith BL, Rajendiran TM, N\u00fa\u00f1ez G (2013) K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38:1142\u20131153","journal-title":"Immunity"},{"key":"4715_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12915-020-00918-w","volume":"18","author":"W Wang","year":"2020","unstructured":"Wang W, Hu D, Feng Y, Wu C, Song Y, Liu W et al (2020) Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome. BMC Biol 18:182","journal-title":"BMC Biol"},{"key":"4715_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fcell.2017.00048","volume":"5","author":"D Lindholm","year":"2017","unstructured":"Lindholm D, Korhonen L, Eriksson O, K\u00f5ks S (2017) Recent insights into the role of unfolded protein response in ER stress in health and disease. Front Cell Dev Biol 5:48","journal-title":"Front Cell Dev Biol"},{"key":"4715_CR55","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1016\/j.bbamcr.2013.07.024","volume":"1833","author":"H Urra","year":"2013","unstructured":"Urra H, Dufey E, Lisbona F, Rojas-Rivera D, Hetz C (2013) When ER stress reaches a dead end. Biochim Biophys Acta 1833:3507\u20133517","journal-title":"Biochim Biophys Acta"},{"key":"4715_CR56","doi-asserted-by":"crossref","unstructured":"Namgaladze D, Khodzhaeva V, Br\u00fcne B (2019) ER-mitochondria communication in cells of the innate immune system. Cells 8(9):1088","DOI":"10.3390\/cells8091088"},{"key":"4715_CR57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2015.08.008","volume":"43","author":"DN Bronner","year":"2015","unstructured":"Bronner DN, Abuaita BH, Chen X, Fitzgerald KA, Nu\u00f1ez G, He Y et al (2015) Endoplasmic reticulum stress activates the inflammasome via NLRP3- and caspase-2-driven mitochondrial damage. Immunity 43:451\u2013462","journal-title":"Immunity"},{"key":"4715_CR58","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1083\/jcb.200604016","volume":"174","author":"G Csord\u00e1s","year":"2006","unstructured":"Csord\u00e1s G, Renken C, V\u00e1rnai P, Walter L, Weaver D, Buttle KF et al (2006) Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol 174:915\u2013921","journal-title":"J Cell Biol"},{"key":"4715_CR59","doi-asserted-by":"crossref","unstructured":"Eysert F, Kinoshita PF, Mary A, Vaillant-Beuchot L, Checler F, Chami M (2020) Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer\u2019s Disease. Int J Mol Sci 21(24):9521","DOI":"10.3390\/ijms21249521"},{"key":"4715_CR60","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.2353\/ajpath.2009.090219","volume":"175","author":"E Area-Gomez","year":"2009","unstructured":"Area-Gomez E, de Groof AJ, Boldogh I, Bird TD, Gibson GE, Koehler CM et al (2009) Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am J Pathol 175:1810\u20131816","journal-title":"Am J Pathol"},{"key":"4715_CR61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrm3440","volume":"13","author":"AA Rowland","year":"2012","unstructured":"Rowland AA, Voeltz GK (2012) Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat Rev Mol Cell Biol 13:607\u2013625","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4715_CR62","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2174\/0929867327666200212100644","volume":"28","author":"M Yang","year":"2021","unstructured":"Yang M, Li C, Sun L (2021) Mitochondria-associated membranes (MAMs): a novel therapeutic target for treating metabolic syndrome. Curr Med Chem 28:1347\u20131362","journal-title":"Curr Med Chem"},{"key":"4715_CR63","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.280.5370.1763","volume":"280","author":"R Rizzuto","year":"1998","unstructured":"Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM et al (1998) Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 280:1763\u20131766","journal-title":"Science"},{"key":"4715_CR64","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1046\/j.1432-1327.1999.00658.x","volume":"264","author":"G Achleitner","year":"1999","unstructured":"Achleitner G, Gaigg B, Krasser A, Kainersdorfer E, Kohlwein SD, Perktold A et al (1999) Association between the endoplasmic reticulum and mitochondria of yeast facilitates interorganelle transport of phospholipids through membrane contact. Eur J Biochem 264:545\u2013553","journal-title":"Eur J Biochem"},{"key":"4715_CR65","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tins.2016.01.008","volume":"39","author":"S Paillusson","year":"2016","unstructured":"Paillusson S, Stoica R, Gomez-Suaga P, Lau DHW, Mueller S, Miller T et al (2016) There\u2019s something wrong with my MAM; the ER-mitochondria axis and neurodegenerative diseases. Trends Neurosci 39:146\u2013157","journal-title":"Trends Neurosci"},{"key":"4715_CR66","doi-asserted-by":"crossref","unstructured":"Area-Gomez E, Del Carmen Lara Castillo M, Tambini MD, Guardia-Laguarta C, de Groof AJ, Madra M et al (2012) Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. Embo J 31:4106\u20134123","DOI":"10.1038\/emboj.2012.202"},{"key":"4715_CR67","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.1073\/pnas.1300677110","volume":"110","author":"L Hedskog","year":"2013","unstructured":"Hedskog L, Pinho CM, Filadi R, R\u00f6nnb\u00e4ck A, Hertwig L, Wiehager B et al (2013) Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer\u2019s disease and related models. Proc Natl Acad Sci U S A 110:7916\u20137921","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4715_CR68","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/CS20200844","volume":"135","author":"W Yu","year":"2021","unstructured":"Yu W, Jin H, Huang Y (2021) Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer\u2019s disease. Clin Sci (Lond) 135:109\u2013126","journal-title":"Clin Sci (Lond)"},{"key":"4715_CR69","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1084\/jem.20162040","volume":"214","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Meszaros G, He WT, Xu Y, de Fatima MH, Mailly L et al (2017) Protein kinase D at the Golgi controls NLRP3 inflammasome activation. J Exp Med 214:2671\u20132693","journal-title":"J Exp Med"},{"key":"4715_CR70","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221\u2013225","journal-title":"Nature"},{"key":"4715_CR71","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"A Alzheimer","year":"1995","unstructured":"Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde.\u201d Clin Anat 8:429\u2013431","journal-title":"Clin Anat"},{"key":"4715_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnins.2018.00025","volume":"12","author":"F Kametani","year":"2018","unstructured":"Kametani F, Hasegawa M (2018) Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease. Front Neurosci 12:25","journal-title":"Front Neurosci"},{"key":"4715_CR73","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3389\/fnins.2019.01274","volume":"13","author":"S Takeda","year":"2019","unstructured":"Takeda S (2019) Tau propagation as a diagnostic and therapeutic target for dementia: potentials and unanswered questions. Front Neurosci 13:1274","journal-title":"Front Neurosci"},{"key":"4715_CR74","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","volume":"705","author":"NN Naseri","year":"2019","unstructured":"Naseri NN, Wang H, Guo J, Sharma M, Luo W (2019) The complexity of tau in Alzheimer\u2019s disease. Neurosci Lett 705:183\u2013194","journal-title":"Neurosci Lett"},{"key":"4715_CR75","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"4715_CR76","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42:631\u2013639","journal-title":"Neurology"},{"key":"4715_CR77","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archneur.1995.00540250089017","volume":"52","author":"LM Bierer","year":"1995","unstructured":"Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL et al (1995) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer\u2019s disease. Arch Neurol 52:81\u201388","journal-title":"Arch Neurol"},{"key":"4715_CR78","doi-asserted-by":"crossref","unstructured":"Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16:285\u201398. discussion 98\u2013304","DOI":"10.1016\/0197-4580(95)00013-5"},{"key":"4715_CR79","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussi\u00e8re T, Bouras C, K\u00f6vari E, Perl DP et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology 60:1495\u20131500","journal-title":"Neurology"},{"issue":"Suppl 1","key":"4715_CR80","first-page":"S8","volume":"36","author":"B Ahlemeyer","year":"2003","unstructured":"Ahlemeyer B, Krieglstein J (2003) Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer\u2019s disease. Pharmacopsychiatry 36(Suppl 1):S8\u201314","journal-title":"Pharmacopsychiatry"},{"key":"4715_CR81","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.2174\/1568026615666150610142647","volume":"15","author":"SM Nabavi","year":"2015","unstructured":"Nabavi SM, Habtemariam S, Daglia M, Braidy N, Loizzo MR, Tundis R et al (2015) Neuroprotective effects of ginkgolide B against ischemic stroke: a review of current literature. Curr Top Med Chem 15:2222\u20132232","journal-title":"Curr Top Med Chem"},{"key":"4715_CR82","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12031-021-01940-5","volume":"72","author":"P Nagu","year":"2022","unstructured":"Nagu P, Sharma V, Behl T, Pathan AKA, Mehta V (2022) Molecular insights to the Wnt signaling during Alzheimer\u2019s disorder: a potential target for therapeutic interventions. J Mol Neurosci 72:679\u2013690","journal-title":"J Mol Neurosci"},{"key":"4715_CR83","doi-asserted-by":"publisher","first-page":"136206","DOI":"10.1016\/j.neulet.2021.136206","volume":"764","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhao Y, Zhang J, Gao Y, Li S, Chang C et al (2021) Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in A\u03b2(1\u201342)-induced microglia cells. Neurosci Lett 764:136206","journal-title":"Neurosci Lett"},{"key":"4715_CR84","doi-asserted-by":"publisher","first-page":"10237","DOI":"10.18632\/aging.205072","volume":"15","author":"GZ Liu","year":"2023","unstructured":"Liu GZ, Niu TT, Yu Q, Xu BL, Li XQ, Yuan BY et al (2023) Ginkgolide attenuates memory impairment and neuroinflammation by suppressing the NLRP3\/caspase-1 pathway in Alzheimer\u2019s disease. Aging (Albany NY) 15:10237\u201310252","journal-title":"Aging (Albany NY)"},{"key":"4715_CR85","doi-asserted-by":"publisher","first-page":"12230","DOI":"10.1021\/acs.jafc.1c05038","volume":"69","author":"J Liu","year":"2021","unstructured":"Liu J, Ye T, Zhang Y, Zhang R, Kong Y, Zhang Y et al (2021) Protective effect of ginkgolide B against cognitive impairment in mice via regulation of gut microbiota. J Agric Food Chem 69:12230\u201312240","journal-title":"J Agric Food Chem"},{"key":"4715_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s41232-022-00209-7","volume":"42","author":"XG Zhou","year":"2022","unstructured":"Zhou XG, Qiu WQ, Yu L, Pan R, Teng JF, Sang ZP et al (2022) Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer\u2019s disease. Inflamm Regen 42:25","journal-title":"Inflamm Regen"},{"key":"4715_CR87","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/cns.12983","volume":"24","author":"J Feng","year":"2018","unstructured":"Feng J, Wang JX, Du YH, Liu Y, Zhang W, Chen JF et al (2018) Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP\/PS1 transgenic mice. CNS Neurosci Ther 24:1207\u20131218","journal-title":"CNS Neurosci Ther"},{"key":"4715_CR88","doi-asserted-by":"crossref","unstructured":"Guo P, Zeng M, Wang S, Cao B, Liu M, Zhang Y et al (2022) Eriodictyol and homoeriodictyol improve memory impairment in A\u03b2(25\u201335)-induced mice by inhibiting the NLRP3 inflammasome. Molecules 27(8):2488","DOI":"10.3390\/molecules27082488"},{"key":"4715_CR89","doi-asserted-by":"publisher","unstructured":"Kour D, Khajuria P, Sharma K, Sharma A, Sharma A, Ali SM et al (2023) Isobavachalcone ameliorates Alzheimer disease pathology by autophagy-mediated clearance of amyloid beta and inhibition of NLRP3 inflammasome in 5XFAD mice. Preprint. https:\/\/doi.org\/10.21203\/rs.3.rs-3762830\/v1","DOI":"10.21203\/rs.3.rs-3762830\/v1"},{"key":"4715_CR90","doi-asserted-by":"publisher","first-page":"809433","DOI":"10.3389\/fnagi.2021.809433","volume":"13","author":"Y Cai","year":"2021","unstructured":"Cai Y, Chai Y, Fu Y, Wang Y, Zhang Y, Zhang X et al (2021) Salidroside ameliorates Alzheimer\u2019s disease by targeting NLRP3 inflammasome-mediated pyroptosis. Front Aging Neurosci 13:809433","journal-title":"Front Aging Neurosci"},{"key":"4715_CR91","doi-asserted-by":"publisher","first-page":"102260","DOI":"10.1016\/j.tice.2023.102260","volume":"85","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Liu X, Liu X, Zhang J, Zhang Y, Wen Y et al (2023) Salvianolic acid B exerts protective effects against A\u03b2-induced neuroinflammation through the inhibition of NLRP3 inflammasome activation and switching of M1\/M2 polarization. Tissue Cell 85:102260","journal-title":"Tissue Cell"},{"key":"4715_CR92","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.1002\/jcb.27023","volume":"119","author":"Q Li","year":"2018","unstructured":"Li Q, Chen L, Liu X, Li X, Cao Y, Bai Y et al (2018) Pterostilbene inhibits amyloid-\u03b2-induced neuroinflammation in a microglia cell line by inactivating the NLRP3\/caspase-1 inflammasome pathway. J Cell Biochem 119:7053\u20137062","journal-title":"J Cell Biochem"},{"key":"4715_CR93","doi-asserted-by":"publisher","first-page":"11097","DOI":"10.1021\/jf303755w","volume":"60","author":"Q Lu","year":"2012","unstructured":"Lu Q, Jiang MH, Jiang JG, Zhang RF, Zhang MW (2012) Isolation and identification of compounds from Penthorum chinense Pursh with antioxidant and antihepatocarcinoma properties. J Agric Food Chem 60:11097\u201311103","journal-title":"J Agric Food Chem"},{"key":"4715_CR94","doi-asserted-by":"publisher","first-page":"11045","DOI":"10.3390\/molecules190811045","volume":"19","author":"D Huang","year":"2014","unstructured":"Huang D, Jiang Y, Chen W, Yao F, Sun L (2014) Polyphenols with anti-proliferative activities from Penthorum chinense Pursh. Molecules 19:11045\u201311055","journal-title":"Molecules"},{"key":"4715_CR95","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1039\/D2FO00357K","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, He L, Wang W, Xie Z, Zhang X, Wang P et al (2022) Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1-Nrf2 protein-protein interaction from Penthorum chinense Pursh. attenuates 6-hydroxydopamine-induced ferroptosis in zebrafish and dopaminergic neurons. Food Funct. 13:7885\u20137900","journal-title":"Food Funct."},{"key":"4715_CR96","doi-asserted-by":"publisher","first-page":"110575","DOI":"10.1016\/j.biopha.2020.110575","volume":"130","author":"WQ Qiu","year":"2020","unstructured":"Qiu WQ, Pan R, Tang Y, Zhou XG, Wu JM, Yu L et al (2020) Lychee seed polyphenol inhibits A\u03b2-induced activation of NLRP3 inflammasome via the LRP1\/AMPK mediated autophagy induction. Biomed Pharmacother 130:110575","journal-title":"Biomed Pharmacother"},{"key":"4715_CR97","doi-asserted-by":"publisher","first-page":"105767","DOI":"10.1016\/j.phrs.2021.105767","volume":"171","author":"S Dong","year":"2021","unstructured":"Dong S, Zhu M, Wang K, Zhao X, Hu L, Jing W et al (2021) Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism. Pharmacol Res 171:105767","journal-title":"Pharmacol Res"},{"key":"4715_CR98","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11064-014-1304-4","volume":"39","author":"J Liang","year":"2014","unstructured":"Liang J, L\u00f3pez-Vald\u00e9s HE, Mart\u00ednez-Coria H, Lindemeyer AK, Shen Y, Shao XM et al (2014) Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer\u2019s disease. Neurochem Res 39:1171\u20131181","journal-title":"Neurochem Res"},{"key":"4715_CR99","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/13880209.2016.1266669","volume":"55","author":"L Liu","year":"2017","unstructured":"Liu L, Yin X, Wang X, Li X (2017) Determination of dihydromyricetin in rat plasma by LC-MS\/MS and its application to a pharmacokinetic study. Pharm Biol 55:657\u2013662","journal-title":"Pharm Biol"},{"key":"4715_CR100","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/1750-3841.14112","volume":"83","author":"D Xiang","year":"2018","unstructured":"Xiang D, Fan L, Hou XL, Xiong W, Shi CY, Wang WQ et al (2018) Uptake and transport mechanism of dihydromyricetin across human intestinal Caco-2 cells. J Food Sci 83:1941\u20131947","journal-title":"J Food Sci"},{"key":"4715_CR101","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3892\/etm.2015.2827","volume":"10","author":"GF Zhu","year":"2015","unstructured":"Zhu GF, Guo HJ, Huang Y, Wu CT, Zhang XF (2015) Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity. Exp Ther Med 10:2259\u20132266","journal-title":"Exp Ther Med"},{"key":"4715_CR102","doi-asserted-by":"publisher","first-page":"4724920","DOI":"10.1155\/2019\/4724920","volume":"2019","author":"S Habtemariam","year":"2019","unstructured":"Habtemariam S (2019) The Nrf2\/HO-1 axis as targets for flavanones: neuroprotection by pinocembrin, naringenin, and eriodictyol. Oxid Med Cell Longev 2019:4724920","journal-title":"Oxid Med Cell Longev"},{"key":"4715_CR103","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s11064-015-1616-z","volume":"40","author":"X Jing","year":"2015","unstructured":"Jing X, Shi H, Zhu X, Wei X, Ren M, Han M et al (2015) Eriodictyol attenuates \u03b2-amyloid 25\u201335 peptide-induced oxidative cell death in primary cultured neurons by activation of Nrf2. Neurochem Res 40:1463\u20131471","journal-title":"Neurochem Res"},{"key":"4715_CR104","doi-asserted-by":"publisher","first-page":"10205","DOI":"10.1021\/acs.jafc.8b03731","volume":"66","author":"P He","year":"2018","unstructured":"He P, Yan S, Zheng J, Gao Y, Zhang S, Liu Z et al (2018) Eriodictyol attenuates LPS-induced neuroinflammation, amyloidogenesis, and cognitive impairments via the inhibition of NF-\u03baB in male C57BL\/6J mice and BV2 microglial cells. J Agric Food Chem 66:10205\u201310214","journal-title":"J Agric Food Chem"},{"key":"4715_CR105","doi-asserted-by":"publisher","first-page":"e1800147","DOI":"10.1002\/mnfr.201800147","volume":"62","author":"YS Yi","year":"2018","unstructured":"Yi YS (2018) Regulatory roles of flavonoids on inflammasome activation during inflammatory responses. Mol Nutr Food Res 62:e1800147","journal-title":"Mol Nutr Food Res"},{"key":"4715_CR106","unstructured":"Li N, Li M, Guo M, Meng T, Mu B, Yu J, et al (2023) [Eriodictyol improves cognitive function in 5\u00d7FAD mice of Alzheimer\u2019s disease by inhibiting the microglia NLRP3 inflammasome signaling pathway]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 39: 973\u201380"},{"key":"4715_CR107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s10020-022-00442-3","volume":"28","author":"L Li","year":"2022","unstructured":"Li L, Li WJ, Zheng XR, Liu QL, Du Q, Lai YJ et al (2022) Eriodictyol ameliorates cognitive dysfunction in APP\/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation. Mol Med 28:11","journal-title":"Mol Med"},{"key":"4715_CR108","unstructured":"Li M, Li N, Guo M, Meng T, Yu J, Li Y, Ma C, Yu J (2023) Eriodictyol improves cognitive function of 5\u00d7FAD mice by regulating Nogo-A\/NgR\/ROCK2 signaling pathway. Chin J Tissue Eng Res 27:5097\u2013102"},{"key":"4715_CR109","doi-asserted-by":"publisher","first-page":"105483","DOI":"10.1016\/j.phrs.2021.105483","volume":"165","author":"M Wang","year":"2021","unstructured":"Wang M, Lin L, Lu JJ, Chen X (2021) Pharmacological review of isobavachalcone, a naturally occurring chalcone. Pharmacol Res 165:105483","journal-title":"Pharmacol Res"},{"key":"4715_CR110","doi-asserted-by":"crossref","unstructured":"Barber K, Mendonca P, Soliman KFA (2023) The neuroprotective effects and therapeutic potential of the chalcone cardamonin for Alzheimer\u2019s disease. Brain Sci 13(1):145","DOI":"10.3390\/brainsci13010145"},{"key":"4715_CR111","doi-asserted-by":"publisher","first-page":"113746","DOI":"10.1016\/j.biopha.2022.113746","volume":"156","author":"M Jin","year":"2022","unstructured":"Jin M, Wang C, Xu Y, Zhang Z, Wu X, Ye R et al (2022) Pharmacological effects of salidroside on central nervous system diseases. Biomed Pharmacother 156:113746","journal-title":"Biomed Pharmacother"},{"key":"4715_CR112","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s12035-014-9045-6","volume":"53","author":"H Jin","year":"2016","unstructured":"Jin H, Pei L, Shu X, Yang X, Yan T, Wu Y et al (2016) Therapeutic intervention of learning and memory decays by salidroside stimulation of neurogenesis in aging. Mol Neurobiol 53:851\u2013866","journal-title":"Mol Neurobiol"},{"key":"4715_CR113","doi-asserted-by":"publisher","first-page":"111949","DOI":"10.1016\/j.biopha.2021.111949","volume":"142","author":"D Song","year":"2021","unstructured":"Song D, Zhao M, Feng L, Wang P, Li Y, Li W (2021) Salidroside attenuates acute lung injury via inhibition of inflammatory cytokine production. Biomed Pharmacother 142:111949","journal-title":"Biomed Pharmacother"},{"key":"4715_CR114","doi-asserted-by":"publisher","first-page":"568423","DOI":"10.3389\/fphar.2020.568423","volume":"11","author":"Z Xie","year":"2020","unstructured":"Xie Z, Lu H, Yang S, Zeng Y, Li W, Wang L et al (2020) Salidroside attenuates cognitive dysfunction in senescence-accelerated mouse prone 8 (SAMP8) mice and modulates inflammation of the gut-brain axis. Front Pharmacol 11:568423","journal-title":"Front Pharmacol"},{"key":"4715_CR115","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13020-022-00634-3","volume":"17","author":"S Yang","year":"2022","unstructured":"Yang S, Xie Z, Pei T, Zeng Y, Xiong Q, Wei H et al (2022) Salidroside attenuates neuronal ferroptosis by activating the Nrf2\/HO1 signaling pathway in A\u03b2(1\u201342)-induced Alzheimer\u2019s disease mice and glutamate-injured HT22 cells. Chin Med 17:82","journal-title":"Chin Med"},{"key":"4715_CR116","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13578-022-00918-z","volume":"12","author":"Y Yao","year":"2022","unstructured":"Yao Y, Ren Z, Yang R, Mei Y, Dai Y, Cheng Q et al (2022) Salidroside reduces neuropathology in Alzheimer\u2019s disease models by targeting NRF2\/SIRT3 pathway. Cell Biosci 12:180","journal-title":"Cell Biosci"},{"key":"4715_CR117","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1002\/ptr.7235","volume":"35","author":"L Zhu","year":"2021","unstructured":"Zhu L, Liu Z, Ren Y, Wu X, Liu Y, Wang T et al (2021) Neuroprotective effects of salidroside on ageing hippocampal neurons and naturally ageing mice via the PI3K\/Akt\/TERT pathway. Phytother Res 35:5767\u20135780","journal-title":"Phytother Res"},{"key":"4715_CR118","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/03639045.2023.2252062","volume":"49","author":"MH Chen","year":"2023","unstructured":"Chen MH, Liu XZ, Qu XW, Guo RB, Zhang L, Kong L et al (2023) ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer\u2019s disease in APP\/PS-1 mice. Drug Dev Ind Pharm 49:559\u2013571","journal-title":"Drug Dev Ind Pharm"},{"key":"4715_CR119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13020-019-0242-0","volume":"14","author":"CM Chong","year":"2019","unstructured":"Chong CM, Su H, Lu JJ, Wang Y (2019) The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer\u2019s disease. Chin Med 14:19","journal-title":"Chin Med"},{"key":"4715_CR120","doi-asserted-by":"crossref","unstructured":"Pellegrini C, Fornai M, Antonioli L, Blandizzi C, Calderone V (2019) Phytochemicals as novel therapeutic strategies for NLRP3 inflammasome-related neurological, metabolic, and inflammatory diseases. Int J Mol Sci 20(12):2872","DOI":"10.3390\/ijms20122876"},{"key":"4715_CR121","doi-asserted-by":"publisher","first-page":"113776","DOI":"10.1016\/j.jep.2021.113776","volume":"270","author":"DC Ma","year":"2021","unstructured":"Ma DC, Zhang NN, Zhang YN, Chen HS (2021) Salvianolic acids for injection alleviates cerebral ischemia\/reperfusion injury by switching M1\/M2 phenotypes and inhibiting NLRP3 inflammasome\/pyroptosis axis in microglia in vivo and in vitro. J Ethnopharmacol 270:113776","journal-title":"J Ethnopharmacol"},{"key":"4715_CR122","doi-asserted-by":"publisher","first-page":"1159958","DOI":"10.3389\/fimmu.2023.1159958","volume":"14","author":"D Xia","year":"2023","unstructured":"Xia D, Yuan J, Wu D, Dai H, Zhuang Z (2023) Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage. Front Immunol 14:1159958","journal-title":"Front Immunol"},{"key":"4715_CR123","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/157488406775268246","volume":"1","author":"KA Roupe","year":"2006","unstructured":"Roupe KA, Remsberg CM, Y\u00e1\u00f1ez JA, Davies NM (2006) Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 1:81\u2013101","journal-title":"Curr Clin Pharmacol"},{"key":"4715_CR124","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/bmc.1254","volume":"23","author":"HS Lin","year":"2009","unstructured":"Lin HS, Yue BD, Ho PC (2009) Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr 23:1308\u20131315","journal-title":"Biomed Chromatogr"},{"key":"4715_CR125","doi-asserted-by":"publisher","first-page":"575482","DOI":"10.1155\/2013\/575482","volume":"2013","author":"D McCormack","year":"2013","unstructured":"McCormack D, McFadden D (2013) A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev 2013:575482","journal-title":"Oxid Med Cell Longev"},{"key":"4715_CR126","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pnpbp.2014.03.015","volume":"54","author":"Y Hou","year":"2014","unstructured":"Hou Y, Xie G, Miao F, Ding L, Mou Y, Wang L et al (2014) Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Prog Neuropsychopharmacol Biol Psychiatry 54:92\u2013102","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4715_CR127","doi-asserted-by":"publisher","first-page":"877098","DOI":"10.3389\/fphar.2022.877098","volume":"13","author":"L Zhu","year":"2022","unstructured":"Zhu L, Lu F, Zhang X, Liu S, Mu P (2022) SIRT1 is involved in the neuroprotection of pterostilbene against amyloid \u03b2 25\u201335-induced cognitive deficits in mice. Front Pharmacol 13:877098","journal-title":"Front Pharmacol"},{"key":"4715_CR128","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jpba.2015.04.045","volume":"114","author":"L Deng","year":"2015","unstructured":"Deng L, Li Y, Zhang X, Chen B, Deng Y, Li Y (2015) UPLC-MS method for quantification of pterostilbene and its application to comparative study of bioavailability and tissue distribution in normal and Lewis lung carcinoma bearing mice. J Pharm Biomed Anal 114:200\u2013207","journal-title":"J Pharm Biomed Anal"},{"key":"4715_CR129","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","volume":"68","author":"IM Kapetanovic","year":"2011","unstructured":"Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL (2011) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 68:593\u2013601","journal-title":"Cancer Chemother Pharmacol"},{"key":"4715_CR130","doi-asserted-by":"publisher","first-page":"107461","DOI":"10.1016\/j.biotechadv.2019.107461","volume":"39","author":"P Jeandet","year":"2020","unstructured":"Jeandet P, Sobarzo-S\u00e1nchez E, Silva AS, Cl\u00e9ment C, Nabavi SF, Battino M et al (2020) Whole-cell biocatalytic, enzymatic and green chemistry methods for the production of resveratrol and its derivatives. Biotechnol Adv 39:107461","journal-title":"Biotechnol Adv"},{"key":"4715_CR131","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1021\/jf803579e","volume":"57","author":"MJ Ruiz","year":"2009","unstructured":"Ruiz MJ, Fern\u00e1ndez M, Pic\u00f3 Y, Ma\u00f1es J, Asensi M, Carda C et al (2009) Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem 57:3180\u20133186","journal-title":"J Agric Food Chem"},{"key":"4715_CR132","doi-asserted-by":"publisher","first-page":"463595","DOI":"10.1155\/2013\/463595","volume":"2013","author":"DM Riche","year":"2013","unstructured":"Riche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D et al (2013) Analysis of safety from a human clinical trial with pterostilbene. J Toxicol 2013:463595","journal-title":"J Toxicol"},{"key":"4715_CR133","doi-asserted-by":"publisher","first-page":"115865","DOI":"10.1016\/j.jep.2022.115865","volume":"302","author":"Z He","year":"2023","unstructured":"He Z, Hu Y, Niu Z, Zhong K, Liu T, Yang M et al (2023) A review of pharmacokinetic and pharmacological properties of asiaticoside, a major active constituent of Centella asiatica (L.) Urb. J Ethnopharmacol. 302:115865","journal-title":"J Ethnopharmacol."},{"key":"4715_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2017.02.005","volume":"155","author":"M Gopi","year":"2017","unstructured":"Gopi M, Arambakkam JV (2017) Asiaticoside: Attenuation of rotenone induced oxidative burden in a rat model of hemiparkinsonism by maintaining the phosphoinositide-mediated synaptic integrity. Pharmacol Biochem Behav 155:1\u201315","journal-title":"Pharmacol Biochem Behav"},{"key":"4715_CR135","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mds.27874","volume":"35","author":"ME Haque","year":"2020","unstructured":"Haque ME, Akther M, Jakaria M, Kim IS, Azam S, Choi DK (2020) Targeting the microglial NLRP3 inflammasome and its role in Parkinson\u2019s disease. Mov Disord 35:20\u201333","journal-title":"Mov Disord"},{"key":"4715_CR136","doi-asserted-by":"publisher","first-page":"155494","DOI":"10.1016\/j.phymed.2024.155494","volume":"127","author":"Z He","year":"2024","unstructured":"He Z, Hu Y, Zhang Y, Xie J, Niu Z, Yang G et al (2024) Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation. Phytomedicine 127:155494","journal-title":"Phytomedicine"},{"key":"4715_CR137","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.chroma.2005.03.088","volume":"1074","author":"HB Li","year":"2005","unstructured":"Li HB, Chen F (2005) Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J Chromatogr A 1074:107\u2013110","journal-title":"J Chromatogr A"},{"key":"4715_CR138","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.intimp.2017.04.019","volume":"48","author":"X Liu","year":"2017","unstructured":"Liu X, Liu C (2017) Baicalin ameliorates chronic unpredictable mild stress-induced depressive behavior: Involving the inhibition of NLRP3 inflammasome activation in rat prefrontal cortex. Int Immunopharmacol 48:30\u201334","journal-title":"Int Immunopharmacol"},{"key":"4715_CR139","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.intimp.2014.09.005","volume":"23","author":"L Cui","year":"2014","unstructured":"Cui L, Feng L, Zhang ZH, Jia XB (2014) The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4\/NF-\u03baB pathway activation. Int Immunopharmacol 23:294\u2013303","journal-title":"Int Immunopharmacol"},{"key":"4715_CR140","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neulet.2011.01.055","volume":"492","author":"F Yin","year":"2011","unstructured":"Yin F, Liu J, Ji X, Wang Y, Zidichouski J, Zhang J (2011) Baicalin prevents the production of hydrogen peroxide and oxidative stress induced by A\u03b2 aggregation in SH-SY5Y cells. Neurosci Lett 492:76\u201379","journal-title":"Neurosci Lett"},{"key":"4715_CR141","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11418-013-0782-z","volume":"68","author":"B Lee","year":"2014","unstructured":"Lee B, Sur B, Shim I, Lee H, Hahm DH (2014) Baicalin improves chronic corticosterone-induced learning and memory deficits via the enhancement of impaired hippocampal brain-derived neurotrophic factor and cAMP response element-binding protein expression in the rat. J Nat Med 68:132\u2013143","journal-title":"J Nat Med"},{"key":"4715_CR142","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.intimp.2012.10.013","volume":"14","author":"J Hou","year":"2012","unstructured":"Hou J, Wang J, Zhang P, Li D, Zhang C, Zhao H et al (2012) Baicalin attenuates proinflammatory cytokine production in oxygen-glucose deprived challenged rat microglial cells by inhibiting TLR4 signaling pathway. Int Immunopharmacol 14:749\u2013757","journal-title":"Int Immunopharmacol"},{"key":"4715_CR143","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00213-018-4833-8","volume":"235","author":"S Ding","year":"2018","unstructured":"Ding S, Zhuge W, Hu J, Yang J, Wang X, Wen F et al (2018) Baicalin reverses the impairment of synaptogenesis induced by dopamine burden via the stimulation of GABA(A)R-TrkB interaction in minimal hepatic encephalopathy. Psychopharmacology 235:1163\u20131178","journal-title":"Psychopharmacology"},{"key":"4715_CR144","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/cns.13086","volume":"25","author":"X Jin","year":"2019","unstructured":"Jin X, Liu MY, Zhang DF, Zhong X, Du K, Qian P et al (2019) Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4\/NF-\u03baB signaling pathway. CNS Neurosci Ther 25:575\u2013590","journal-title":"CNS Neurosci Ther"},{"key":"4715_CR145","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/MCO.0000000000000511","volume":"21","author":"AA Panjwani","year":"2018","unstructured":"Panjwani AA, Liu H, Fahey JW (2018) Crucifers and related vegetables and supplements for neurologic disorders: what is the evidence? Curr Opin Clin Nutr Metab Care 21:451\u2013457","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"4715_CR146","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","volume":"79","author":"C Manach","year":"2004","unstructured":"Manach C, Scalbert A, Morand C, R\u00e9m\u00e9sy C, Jim\u00e9nez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727\u2013747","journal-title":"Am J Clin Nutr"},{"key":"4715_CR147","doi-asserted-by":"publisher","first-page":"7361613","DOI":"10.1155\/2016\/7361613","volume":"2016","author":"SK Singh","year":"2016","unstructured":"Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G (2016) Overview of Alzheimer\u2019s disease and some therapeutic approaches targeting A\u03b2 by using several synthetic and herbal compounds. Oxid Med Cell Longev 2016:7361613","journal-title":"Oxid Med Cell Longev"},{"key":"4715_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2015.10.016","volume":"38","author":"YW An","year":"2016","unstructured":"An YW, Jhang KA, Woo SY, Kang JL, Chong YH (2016) Sulforaphane exerts its anti-inflammatory effect against amyloid-\u03b2 peptide via STAT-1 dephosphorylation and activation of Nrf2\/HO-1 cascade in human THP-1 macrophages. Neurobiol Aging 38:1\u201310","journal-title":"Neurobiol Aging"},{"key":"4715_CR149","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.imlet.2021.03.004","volume":"233","author":"KU Tufekci","year":"2021","unstructured":"Tufekci KU, Ercan I, Isci KB, Olcum M, Tastan B, Gonul CP et al (2021) Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration. Immunol Lett 233:20\u201330","journal-title":"Immunol Lett"},{"key":"4715_CR150","doi-asserted-by":"publisher","first-page":"148206","DOI":"10.1016\/j.brainres.2022.148206","volume":"1801","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhang J, Yang C, Dong B, Fu Y, Wang Y et al (2023) Sulforaphane attenuates microglia-mediated neuronal damage by down-regulating the ROS\/autophagy\/NLRP3 signal axis in fibrillar A\u03b2-activated microglia. Brain Res 1801:148206","journal-title":"Brain Res"},{"key":"4715_CR151","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41423-021-00683-y","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, He H, Lin B, Chen Y, Deng X, Jiang W et al (2021) RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Cell Mol Immunol 18:1425\u20131436","journal-title":"Cell Mol Immunol"},{"key":"4715_CR152","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","volume":"64","author":"AG Schwaid","year":"2021","unstructured":"Schwaid AG, Spencer KB (2021) Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space. J Med Chem 64:101\u2013122","journal-title":"J Med Chem"},{"key":"4715_CR153","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","volume":"91","author":"S Darakhshan","year":"2015","unstructured":"Darakhshan S, Pour AB (2015) Tranilast: a review of its therapeutic applications. Pharmacol Res 91:15\u201328","journal-title":"Pharmacol Res"},{"key":"4715_CR154","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, Jansen T, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW et al (2020) Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol 2:e270\u2013e280","journal-title":"Lancet Rheumatol"},{"key":"4715_CR155","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/cpdd.1162","volume":"12","author":"DV Parmar","year":"2023","unstructured":"Parmar DV, Kansagra KA, Momin T, Patel HB, Jansari GA, Bhavsar J et al (2023) Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral NLRP3 inflammasome inhibitor ZYIL1: first-in-human phase 1 studies (single ascending dose and multiple ascending dose). Clin Pharmacol Drug Dev 12:202\u2013211","journal-title":"Clin Pharmacol Drug Dev"},{"key":"4715_CR156","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s15010-022-01904-w","volume":"51","author":"I Madurka","year":"2023","unstructured":"Madurka I, Vishnevsky A, Soriano JB, Gans SJ, Ore DJS, Rendon A et al (2023) DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function. Infection 51:641\u2013654","journal-title":"Infection"},{"key":"4715_CR157","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","volume":"23","author":"L Vande Walle","year":"2024","unstructured":"Vande Walle L, Lamkanfi M (2024) Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov 23:43\u201366","journal-title":"Nat Rev Drug Discov"},{"key":"4715_CR158","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","volume":"66","author":"D Harrison","year":"2023","unstructured":"Harrison D, Billinton A, Bock MG, Doedens JR, Gabel CA, Holloway MK et al (2023) Discovery of clinical candidate NT-0796, a brain-penetrant and highly potent NLRP3 inflammasome inhibitor for neuroinflammatory disorders. J Med Chem 66:14897\u201314911","journal-title":"J Med Chem"},{"key":"4715_CR159","doi-asserted-by":"publisher","first-page":"101310","DOI":"10.1016\/j.xcrm.2023.101310","volume":"4","author":"X Jin","year":"2023","unstructured":"Jin X, Liu D, Zhou X, Luo X, Huang Q, Huang Y (2023) Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7. Cell Rep Med 4:101310","journal-title":"Cell Rep Med"},{"key":"4715_CR160","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41401-023-01212-5","volume":"45","author":"JJ Shao","year":"2024","unstructured":"Shao JJ, Li WF, Sun JF, Zhuang ZS, Min JL, Long XH et al (2024) Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice. Acta Pharmacol Sin 45:803\u2013814","journal-title":"Acta Pharmacol Sin"},{"key":"4715_CR161","doi-asserted-by":"publisher","first-page":"1307739","DOI":"10.3389\/fimmu.2023.1307739","volume":"14","author":"K Park","year":"2023","unstructured":"Park K, Shin I, Kim Y, Kang H, Oh SJ, Jang E et al (2023) A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout. Front Immunol 14:1307739","journal-title":"Front Immunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04715-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04715-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04715-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:02:15Z","timestamp":1747195335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04715-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":161,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4715"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04715-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Clinical trial number"}}]}}